IL103283A - History of acid 2 carboxyalkyl - 2 indan - carboxamide-oxo-tricyclic benzazepine carboxylic acid, used as inhibitors of encephalins and ECA - Google Patents
History of acid 2 carboxyalkyl - 2 indan - carboxamide-oxo-tricyclic benzazepine carboxylic acid, used as inhibitors of encephalins and ECAInfo
- Publication number
- IL103283A IL103283A IL10328392A IL10328392A IL103283A IL 103283 A IL103283 A IL 103283A IL 10328392 A IL10328392 A IL 10328392A IL 10328392 A IL10328392 A IL 10328392A IL 103283 A IL103283 A IL 103283A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- alkyl
- group
- hydrogen
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76728991A | 1991-09-27 | 1991-09-27 | |
US92948292A | 1992-08-20 | 1992-08-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL103283A0 IL103283A0 (en) | 1993-02-21 |
IL103283A true IL103283A (en) | 1999-04-11 |
Family
ID=27117892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10328392A IL103283A (en) | 1991-09-27 | 1992-09-24 | History of acid 2 carboxyalkyl - 2 indan - carboxamide-oxo-tricyclic benzazepine carboxylic acid, used as inhibitors of encephalins and ECA |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0534396B1 (es) |
JP (1) | JP3173674B2 (es) |
KR (1) | KR100271242B1 (es) |
AT (1) | ATE143972T1 (es) |
AU (1) | AU657793B2 (es) |
CA (1) | CA2079143C (es) |
DE (1) | DE69214397T2 (es) |
DK (1) | DK0534396T3 (es) |
ES (1) | ES2095380T3 (es) |
FI (1) | FI101302B1 (es) |
GR (1) | GR3021420T3 (es) |
HU (1) | HU214821B (es) |
IL (1) | IL103283A (es) |
NO (1) | NO300846B1 (es) |
NZ (1) | NZ244462A (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0534363B1 (en) * | 1991-09-27 | 1997-07-09 | Merrell Pharmaceuticals Inc. | Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
US5552397A (en) * | 1992-05-18 | 1996-09-03 | E. R. Squibb & Sons, Inc. | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase |
DK0656001T3 (da) * | 1992-08-24 | 2000-04-03 | Merrell Pharma Inc | Nye 2-substituerede indan-2-mercaptoacetylamid-tricycliske derivater til anvendelse som enkefalinasehæmmere |
US5504080A (en) * | 1992-10-28 | 1996-04-02 | Bristol-Myers Squibb Co. | Benzo-fused lactams |
US5654294A (en) * | 1993-05-13 | 1997-08-05 | Bristol-Myers Squibb | Spiro lactam dual action inhibitors |
US5508272A (en) * | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
AU7186094A (en) * | 1993-06-30 | 1995-01-24 | Ciba-Geigy Ag | Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
US5362727A (en) * | 1993-07-26 | 1994-11-08 | Bristol-Myers Squibb | Substituted azepino[2,1-a]isoquinoline compounds |
US5594106A (en) * | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
US5525723A (en) * | 1993-11-18 | 1996-06-11 | Bristol-Myers Squibb Co. | Compounds containing a fused multiple ring lactam |
EP0745081B1 (en) * | 1994-02-14 | 2001-11-21 | Merrell Pharmaceuticals Inc. | indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
EP0746566A1 (en) * | 1994-02-14 | 1996-12-11 | Merrell Pharmaceuticals Inc. | Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
EP0750631B1 (en) * | 1994-02-14 | 2000-04-05 | Merrell Pharmaceuticals Inc. | Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
US5616775A (en) * | 1994-05-05 | 1997-04-01 | Bristol-Myers Squibb Co. | Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring |
US5641880A (en) * | 1994-12-21 | 1997-06-24 | Hoechst Marion Roussel, Inc. | Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
DE69533002T2 (de) * | 1994-12-21 | 2005-05-04 | Aventis Pharmaceuticals Inc. | Verfahren zur Herstellung von Zwischenprodukten von Inhibitoren Von Enkephalinase und Angiotensin konvertierendem Enzym und Zwischenprodukte davon |
US5587375A (en) * | 1995-02-17 | 1996-12-24 | Bristol-Myers Squibb Company | Azepinone compounds useful in the inhibition of ACE and NEP |
DE19510566A1 (de) * | 1995-03-23 | 1996-09-26 | Kali Chemie Pharma Gmbh | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US5877313A (en) | 1995-05-17 | 1999-03-02 | Bristol-Myers Squibb | Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
US5635504A (en) * | 1995-06-07 | 1997-06-03 | Bristol-Myers Squibb Co. | Diazepine containing dual action inhibitors |
US5650408A (en) * | 1995-06-07 | 1997-07-22 | Karanewsky; Donald S. | Thiazolo benzazepine containing dual action inhibitors |
WO1999065500A1 (en) | 1998-06-17 | 1999-12-23 | Bristol-Myers Squibb Company | Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
WO2001015674A2 (en) | 1999-08-30 | 2001-03-08 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
GB0119305D0 (en) | 2001-04-12 | 2001-10-03 | Aventis Pharma Gmbh | Mercaptoacetylamide derivatives,a process for their preparation and their use |
EP1443919A4 (en) | 2001-11-16 | 2006-03-22 | Bristol Myers Squibb Co | DOUBLE INHIBITORS OF THE FATTY ACID BINDING PROTEIN OF THE ADIPOCYTES AND THE FATTY ACID BINDING PROTEIN OF KERATINOCYTES |
US7459474B2 (en) | 2003-06-11 | 2008-12-02 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor and method |
US7371759B2 (en) | 2003-09-25 | 2008-05-13 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
US7420059B2 (en) | 2003-11-20 | 2008-09-02 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
US7273881B2 (en) | 2004-01-16 | 2007-09-25 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7888381B2 (en) | 2005-06-14 | 2011-02-15 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof |
US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7795291B2 (en) | 2006-07-07 | 2010-09-14 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method |
WO2008057862A2 (en) | 2006-11-01 | 2008-05-15 | Bristol-Myers Squibb Company | MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF |
EP2099767A1 (en) | 2006-11-01 | 2009-09-16 | Brystol-Myers Squibb Company | Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof |
WO2008057855A2 (en) | 2006-11-01 | 2008-05-15 | Bristol-Myers Squibb Company | Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP2065373A1 (de) | 2007-11-30 | 2009-06-03 | Bayer CropScience AG | Chirale 3-(Benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazol-Derivate und 5,5-Dimethyl-3-[(1H-pyrazol-4-ylmethyl) sulfinyl]-4,5-dihydroisoxazol-Derivate, Verfahren zu deren Herstellung sowie deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
EP2065374A1 (de) | 2007-11-30 | 2009-06-03 | Bayer CropScience AG | 2-(Benzyl- und 1H-pyrazol-4-ylmethyl)sulfinyl-Thiazol-Derivate als Herbizide und Pflanzenwachstumsregulatoren |
EP3239170B1 (en) | 2008-06-04 | 2019-03-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
CN102149710A (zh) | 2008-06-24 | 2011-08-10 | 百时美施贵宝公司 | 糖皮质激素受体、AP-1和/或NF-κB 活性的环戊噻吩调节剂及其用途 |
EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US8546377B2 (en) | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
US8877815B2 (en) | 2010-11-16 | 2014-11-04 | Novartis Ag | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
US9593113B2 (en) | 2013-08-22 | 2017-03-14 | Bristol-Myers Squibb Company | Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552889A (en) * | 1983-06-09 | 1985-11-12 | Eli Lilly And Company | 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension |
ZA874107B (es) * | 1986-06-13 | 1987-12-09 | ||
ZA874106B (en) * | 1986-06-13 | 1987-12-08 | Merrell Dow Pharmaceuticals Inc. | Novel antihypertensive agent |
CA2053340C (en) * | 1990-10-18 | 2002-04-02 | Timothy P. Burkholder | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
CA2057786C (en) * | 1990-12-21 | 2002-06-18 | Gary A. Flynn | Amino and nitro containing tricyclic compounds useful as inhibitors or ace |
EP0534363B1 (en) * | 1991-09-27 | 1997-07-09 | Merrell Pharmaceuticals Inc. | Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
-
1992
- 1992-09-22 AU AU25246/92A patent/AU657793B2/en not_active Ceased
- 1992-09-23 DE DE69214397T patent/DE69214397T2/de not_active Expired - Lifetime
- 1992-09-23 AT AT92116264T patent/ATE143972T1/de not_active IP Right Cessation
- 1992-09-23 DK DK92116264.0T patent/DK0534396T3/da active
- 1992-09-23 EP EP92116264A patent/EP0534396B1/en not_active Expired - Lifetime
- 1992-09-23 NZ NZ244462A patent/NZ244462A/xx unknown
- 1992-09-23 ES ES92116264T patent/ES2095380T3/es not_active Expired - Lifetime
- 1992-09-24 IL IL10328392A patent/IL103283A/en not_active IP Right Cessation
- 1992-09-25 FI FI924310A patent/FI101302B1/fi not_active IP Right Cessation
- 1992-09-25 NO NO923745A patent/NO300846B1/no not_active IP Right Cessation
- 1992-09-25 HU HU9203075A patent/HU214821B/hu not_active IP Right Cessation
- 1992-09-25 CA CA002079143A patent/CA2079143C/en not_active Expired - Lifetime
- 1992-09-25 JP JP28066892A patent/JP3173674B2/ja not_active Expired - Lifetime
- 1992-09-26 KR KR1019920017616A patent/KR100271242B1/ko not_active IP Right Cessation
-
1996
- 1996-10-23 GR GR960402792T patent/GR3021420T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO300846B1 (no) | 1997-08-04 |
JPH05230060A (ja) | 1993-09-07 |
CA2079143C (en) | 2004-03-16 |
EP0534396B1 (en) | 1996-10-09 |
AU657793B2 (en) | 1995-03-23 |
HU9203075D0 (en) | 1992-12-28 |
HU214821B (hu) | 1998-06-29 |
DE69214397T2 (de) | 1997-03-06 |
FI101302B (fi) | 1998-05-29 |
KR100271242B1 (ko) | 2001-02-01 |
EP0534396A2 (en) | 1993-03-31 |
KR930006028A (ko) | 1993-04-20 |
AU2524692A (en) | 1993-04-01 |
DK0534396T3 (da) | 1996-11-18 |
NO923745D0 (no) | 1992-09-25 |
NZ244462A (en) | 1994-08-26 |
NO923745L (no) | 1993-03-29 |
FI101302B1 (fi) | 1998-05-29 |
HUT65278A (en) | 1994-05-02 |
CA2079143A1 (en) | 1993-03-28 |
JP3173674B2 (ja) | 2001-06-04 |
IL103283A0 (en) | 1993-02-21 |
EP0534396A3 (en) | 1993-06-09 |
ATE143972T1 (de) | 1996-10-15 |
DE69214397D1 (de) | 1996-11-14 |
GR3021420T3 (en) | 1997-01-31 |
FI924310A (fi) | 1993-03-28 |
FI924310A0 (fi) | 1992-09-25 |
ES2095380T3 (es) | 1997-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0534396B1 (en) | 2-Substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace | |
EP0534492B1 (en) | Carboxyalkyl substituted inhibitors of enkephalinase and ACE | |
EP0534363B1 (en) | Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | |
EP0481522B1 (en) | Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | |
CA2130116C (en) | Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | |
US5430145A (en) | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | |
US5457196A (en) | 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE | |
US5488047A (en) | Carboxyalkyl tricylic derivatives useful as inhibitors of enkephalinase and ace | |
US5527795A (en) | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |